Thermo Fisher Scientific/$TMO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
Ticker
$TMO
Sector
Primary listing
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
125,000
ISIN
US8835561023
Website
TMO Metrics
BasicAdvanced
$156B
24.16
$17.06
0.78
$1.60
0.42%
Price and volume
Market cap
$156B
Beta
0.78
52-week high
$622.30
52-week low
$385.46
Average daily volume
2.6M
Dividend rate
$1.60
Financial strength
Current ratio
1.775
Quick ratio
1.197
Long term debt to equity
63.393
Total debt to equity
69.231
Dividend payout ratio (TTM)
9.16%
Interest coverage (TTM)
5.90%
Profitability
EBITDA (TTM)
10,826
Gross margin (TTM)
41.37%
Net profit margin (TTM)
15.18%
Operating margin (TTM)
18.30%
Effective tax rate (TTM)
6.74%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
5.00%
Return on equity (TTM)
13.70%
Valuation
Price to earnings (TTM)
24.164
Price to revenue (TTM)
3.66
Price to book
3.15
Price to tangible book (TTM)
-12.52
Price to free cash flow (TTM)
23.352
Free cash flow yield (TTM)
4.28%
Free cash flow per share (TTM)
1,764.83%
Dividend yield (TTM)
0.39%
Forward dividend yield
0.42%
Growth
Revenue change (TTM)
0.96%
Earnings per share change (TTM)
9.37%
3-year revenue growth (CAGR)
1.42%
10-year revenue growth (CAGR)
9.76%
3-year earnings per share growth (CAGR)
-3.85%
10-year earnings per share growth (CAGR)
14.75%
3-year dividend per share growth (CAGR)
14.00%
10-year dividend per share growth (CAGR)
10.31%
What the Analysts think about TMO
Analyst ratings (Buy, Hold, Sell) for Thermo Fisher Scientific stock.
Bulls say / Bears say
Thermo Fisher Scientific reported stronger-than-expected earnings and revenue for Q1 2025, driven by steady demand for its tools and services used in clinical research and therapy development. (reuters.com)
The company announced a $2 billion investment in the U.S. over the next four years, aiming to enhance and expand manufacturing operations and focus on high-impact innovation. (businesswire.com)
Analysts have set an average 12-month price target of $641.56 for Thermo Fisher, indicating potential upside from current levels. (benzinga.com)
Thermo Fisher's acquisition of Solventum's purification and filtration business for $4.1 billion is expected to be dilutive to adjusted per share profit by 6 cents in the first year. (reuters.com)
The company reported Q3 2024 revenue of $10.60 billion, slightly below analyst expectations, indicating potential challenges in meeting revenue forecasts. (reuters.com)
Scotiabank issued a pessimistic forecast for Thermo Fisher's stock price, suggesting potential downside risks. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 23 Jun 2025.
TMO Financial Performance
Revenues and expenses
TMO Earnings Performance
Company profitability
TMO News
AllArticlesVideos
3Q Investing Outlook: Why Farmer Likes PEP, TMO, UNH
Schwab Network·7 days ago
Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More
GlobeNewsWire·1 week ago
Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul15
Thermo Fisher Scientific
Dividend·Payment
$0.43Per share
FAQs
What’s the current market cap for Thermo Fisher Scientific stock?
Thermo Fisher Scientific (TMO) has a market cap of $156B as of June 27, 2025.
What is the P/E ratio for Thermo Fisher Scientific stock?
The price to earnings (P/E) ratio for Thermo Fisher Scientific (TMO) stock is 24.16 as of June 27, 2025.
Does Thermo Fisher Scientific stock pay dividends?
Yes, the Thermo Fisher Scientific (TMO) stock pays dividends to shareholders. As of June 27, 2025, the dividend rate is $1.6 and the yield is 0.42%. Thermo Fisher Scientific has a payout ratio of 9.16% on a trailing twelve-month basis.
When is the next Thermo Fisher Scientific dividend payment date?
The next Thermo Fisher Scientific (TMO) dividend payment is scheduled for July 15, 2025.
What is the beta indicator for Thermo Fisher Scientific?
Thermo Fisher Scientific (TMO) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.